Varian Medical Systems Finland Oy

Varian Medical Systems Finland Oy specializes in radiation therapy software, with a focus on treatment planning systems. Their core product, the Eclipse Treatment Planning System, is designed to help clinicians develop precise radiation treatment plans for cancer patients, particularly for external beam radiation therapy. This software is tailored to optimize delivery accuracy in radiation oncology.

Varian Medical Systems Finland Oy is based in the United States, where it operates under U.S. regulatory frameworks. Since its devices are software-based medical devices used in critical applications like radiation therapy, they must comply with U.S. regulations—such as FDA requirements—without implying any specific approval status for the company itself. Individual devices undergo their own regulatory evaluation.

Varian’s radiation therapy software, including the Eclipse Treatment Planning System, is listed in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify medical devices authorized for use in the U.S., ensuring transparency in the supply chain and compliance with regulatory requirements.

Varian’s radiation therapy software falls under Class II medical device classification. This classification is assigned based on the device’s intended use and risk level—Class II devices generally pose moderate risks and require special controls beyond general good manufacturing practices to ensure safety and effectiveness in clinical settings.